Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

This is a newly introduced balance support supplement, carefully formulated with natural ingredients to enhance brain ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

The Massachusetts based biotech will now press ahead with human trials for its antisense oligonucleotide (ASO) therapy, ...

Corticobasal degeneration (CBD ... In PSP, there is gross midbrain atrophy and neuronal loss, gliosis and abundant neurofibrillary tangles and neuropil threads in many brain regions.